Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri

Xiaowei Zhou,Yue Liu,Yitian Gao,Yuanxing Wang,Qiang Xia,Ruimin Zhong,Chengbang Ma,Mei Zhou,Xinping Xi,Chris Shaw,Tianbao Chen,Di Wu,Hang Fai Kwok,Lei Wang

DOI: https://doi.org/10.3390/toxins12080484

IF: 5.075

2020-07-30

Toxins

Abstract:Antimicrobial peptides (AMPs) are promising therapeutic alternatives compared to conventional antibiotics for the treatment of drug-resistant bacterial infections. However, the application of the overwhelming majority of AMPs is limited because of the high toxicity and high manufacturing costs. Amphibian skin secretion has been proven to be a promising source for the discovery and development of novel AMPs. Herein, we discovered a novel AMP from the skin secretion of Odorrana schmackeri, and designed the analogues by altering the key factors, including conformation, net charge and amphipathicity, to generate short AMPs with enhanced therapeutic efficacy. All the peptides were chemically synthesised, followed by evaluating their biological activity, stability and cytotoxicity. OSd, OSe and OSf exhibited broad-spectrum antibacterial effects, especially OSf, which presented the highest therapeutic index for the tested bacteria. Moreover, these peptides displayed good stability. The results from scanning electron microscopy and transmission electron microscopy studies, indicated that brevinin-OS, OSd, OSe and OSf possessed rapid bactericidal ability by disturbing membrane permeability and causing the release of cytoplasmic contents. In addition, OSd, OSe and OSf dramatically decreased the mortality of waxworms acutely infected with MRSA. Taken together, these data suggested that a balance between positive charge, degrees of α-helicity and hydrophobicity, is necessary for maintaining antimicrobial activity, and these data successfully contributed to the design of short AMPs with significant bactericidal activity and cell selectivity.

toxicology,food science & technology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop new antimicrobial peptides (AMPs) in order to address the problem of the poor effectiveness of traditional antibiotic treatment for drug - resistant bacterial infections. Specifically, researchers discovered a new brevinin - 1 peptide from the skin secretions of Odorrana schmackeri (a type of frog), and designed multiple analogues by modifying its N - terminal region, aiming to enhance the antibacterial activity of these peptides while reducing their toxicity and manufacturing costs. The focus of the research is on optimizing the physicochemical properties of peptides, such as net charge, α - helicity and hydrophilicity, to strengthen their antibacterial effect and cell selectivity. Through this series of experiments, researchers hope to find short peptides with significant bactericidal activity and low toxicity, providing theoretical and experimental bases for the design of new antibacterial drugs.

Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri

Bomidin: an Optimized Antimicrobial Peptide with Broad Antiviral Activity Against Enveloped Viruses.

Discovery and Analysis of a Novel Antimicrobial Peptide B1AW from the Skin Secretion of Amolops Wuyiensis and Improving the Membrane-binding Affinity through the Construction of the Lysine-introduced Analogue

A frog‐derived antimicrobial peptide as a potential anti‐biofilm agent in combating Staphylococcus aureus skin infection

Antimicrobial activity of novel symmetrical antimicrobial peptides centered on a hydrophilic motif against resistant clinical isolates: in vitro and in vivo analyses

Discovery, development and optimisation of a novel frog antimicrobial peptide with combined mode of action against drug-resistant bacteria

Identification and Rational Design of a Novel Antibacterial Peptide Dermaseptin-AC from the Skin Secretion of the Red-Eyed Tree Frog Agalychnis callidryas

A Novel Antimicrobial Peptide Spampcin56-86 from Scylla paramamosain Exerting Rapid Bactericidal and Anti-Biofilm Activity In Vitro and Anti-Infection In Vivo

Improving the Activity of Antimicrobial Peptides Against Aquatic Pathogen Bacteria by Amino Acid Substitutions and Changing the Ratio of Hydrophobic Residues

de Novo-designed antimicrobial peptides with broad-spectrum antimicrobial potency and rapid wound disinfection

A Novel Amphibian Antimicrobial Peptide, Phylloseptin-PV1, Exhibits Effective Anti-staphylococcal Activity Without Inducing Either Hepatic or Renal Toxicity in Mice

In vitro activities of a novel antimicrobial peptide isolated from phyllomedusa tomopterna

The Trp-rich Antimicrobial Amphiphiles with Intramolecular Aromatic Interactions for the Treatment of Bacterial Infection

Design and Synthesis of New N-terminal Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent in Vitro Biological Activity.

Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues

Mining and characterization of novel antimicrobial peptides from the large-scale microbiome of Shanxi aged vinegar based on metagenomics, molecular dynamics simulations and mechanism validation

Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency

A Novel Antimicrobial Peptide Scyreptin1-30 from Scylla Paramamosain Exhibiting Potential Therapy of Pseudomonas Aeruginosa Early Infection in a Mouse Burn Wound Model.

A Novel Antimicrobial Peptide Spampcin<sub>56-86</sub> from <i>Scylla paramamosain</i> Exerting Rapid Bactericidal and Anti-Biofilm Activity In Vitro and Anti-Infection In Vivo

Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus

Strategic modification of low-activity natural antimicrobial peptides confers antibacterial potential in vitro and in vivo